PPARGC1A and colitis: Importantly, its levels are reduced in IBD and in experimental models of colitis, and its IEC-specific deletion in mice (PGC-1α ΔIEC) results in increased susceptibility to experimental colitis induced by dextran sodium sulfate (DSS)12.